These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19300890)

  • 1. Regional origin and decrease of pain in patients with depressive symptoms under treatment with venlafaxine.
    Begré S; Traber M; Gerber M; von Känel R
    Soc Psychiatry Psychiatr Epidemiol; 2010 Jan; 45(1):17-24. PubMed ID: 19300890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care.
    Begré S; Traber M; Gerber M; von Känel R
    Eur Psychiatry; 2008 Apr; 23(3):178-86. PubMed ID: 18328675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician speciality and pain reduction in patients with depressive symptoms under treatment with venlafaxine.
    Begré S; Traber M; Gerber M; von Känel R
    Eur Psychiatry; 2010 Dec; 25(8):455-60. PubMed ID: 20427156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of venlafaxine in depressive illness in general practice.
    Lecrubier Y; Bourin M; Moon CA; Schifano F; Blanchard C; Danjou P; Hackett D
    Acta Psychiatr Scand; 1997 Jun; 95(6):485-93. PubMed ID: 9242843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of "easy-to-use" clinical predictors of early response.
    Rej S; Dew MA; Karp JF
    Pain Med; 2014 Jul; 15(7):1154-62. PubMed ID: 25040462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impacts of migraine and anxiety disorders on painful physical symptoms among patients with major depressive disorder.
    Hung CI; Liu CY; Chen CY; Yang CH; Wang SJ
    J Headache Pain; 2014 Nov; 15(1):73. PubMed ID: 25382691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine for the treatment of chronic pain.
    Songer DA; Schulte H
    Am J Psychiatry; 1996 May; 153(5):737. PubMed ID: 8615433
    [No Abstract]   [Full Text] [Related]  

  • 8. [Headaches of tension and psychogenic headaches: assessment of the treatment with venlafaxine].
    Diukova GM; Toropina GG; Kovalchuk MO; Semenov RV; Troshneva A
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):37-41. PubMed ID: 20517224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.
    Katz IR; Reynolds CF; Alexopoulos GS; Hackett D
    J Am Geriatr Soc; 2002 Jan; 50(1):18-25. PubMed ID: 12028242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine-tramadol similarities.
    Markowitz JS; Patrick KS
    Med Hypotheses; 1998 Aug; 51(2):167-8. PubMed ID: 9881825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large open-label study of venlafaxine in depressed outpatients by community-based physicians.
    Joffe RT; Marshall AM; Lee DK
    J Clin Psychiatry; 1998 Oct; 59(10):515-20. PubMed ID: 9818632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients.
    Malhotra S; King KH; Welge JA; Brusman-Lovins L; McElroy SL
    J Clin Psychiatry; 2002 Sep; 63(9):802-6. PubMed ID: 12363121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venlafaxine in the treatment of resistant postpsychotic depressive symptoms of schizophrenia.
    Mazeh D; Melamed Y; Elizur A
    J Clin Psychopharmacol; 1999 Jun; 19(3):284-5. PubMed ID: 10350042
    [No Abstract]   [Full Text] [Related]  

  • 14. [Characteristics of patients suffering from chronic pain with depressive symptoms in three different treatment settings].
    Begré S; Traber M; Gerber M; von Känel R
    Med Klin (Munich); 2010 Jun; 105(6):393-8. PubMed ID: 20582498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of venlafaxine extended-release monotherapy for first-episode depression with painful physical symptoms.
    Huang X; Li C; Luo YL; Wang B; Ji JL
    Neuroreport; 2013 May; 24(7):364-9. PubMed ID: 23511776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G; Frare F; Toni C; Ruffolo G; Torti C
    Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.
    Rickels K; Pollack MH; Sheehan DV; Haskins JT
    Am J Psychiatry; 2000 Jun; 157(6):968-74. PubMed ID: 10831478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia.
    Gentil V; Kerr-Correa F; Moreno R; D'Arrigo Busnello E; De Campos JA; Juruena MF; Lafer B; Moreno DH; De Cassia Rodrigues RL; Tiosso A; Benedictis E
    J Psychopharmacol; 2000 Mar; 14(1):61-6. PubMed ID: 10757255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of venlafaxine extended release in patients with major depressive disorder.
    Plesnicar BK
    Psychiatr Danub; 2010 Sep; 22(3):413-7. PubMed ID: 20856184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode.
    Amsterdam J
    J Clin Psychopharmacol; 1998 Oct; 18(5):414-7. PubMed ID: 9790160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.